Senators from both sides of the aisle have pledged their support for new legislation to give the FDA more control over compounding pharmacies. The agency claims that they needed increased power of such pharmacies, especially in light of a fungal meningitis outbreak that has already killed at least 32 people.
The legislation would turn control of these pharmacies over to the FDA from state health boards, allowing the federal agency to control both manufacturing and distribution of widely needed drugs.
Sen. Lamar Alexander (R-Tenn.) spoke on the potential bill with MedPage Today on Thursday saying:
"We don't need to disturb the local drugstores and we don't need to do more about the big manufacturers. We need to make sure that when a hospital in Tennessee buys a steroid that it buys it from a manufacturer that is regulated by the FDA, or it buys it from a pharmacy that is properly regulated."
For comments and feedback contact: editorial@rttnews.com
Health News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.